Post by
db2067 on Nov 26, 2021 8:05am
Skymount
They are still negotiating with Skymount Medical, I figure the longer it takes then the more comprehensive the deal/JV is that they are ironing out. They said the scopre may expand:
"There is potential to expand the scope of this collaboration in the future based on certain events and circumstances. Negotiations with Skymount are ongoing"
June 24, 2021 Satellos / iCo Therapeutics PROPOSED PLAN OF ARRANGEMENT "iCo is currently exploring partnering options and pursuing funding sources to initiate its intended Phase 2 trial of iCo019 during 2021. On December 31, 2020 iCo announced that it had executed a non-binding Memorandum of Understanding with Skymount Medical Inc. (“Skymount”) to develop iCo-019. Skymount agrees to initially commit up to US$550,000 to the iCo-019 program. These funds will support preclinical studies assessing iCo-019’s potential as a treatment for infections related to COVID-19. There is potential to expand the scope of this collaboration in the future based on certain events and circumstances. Negotiations with Skymount are ongoing"